Global Tobacco Alternative Gums Market 2017-2021

タバコ代替ガムの世界市場2017-2021

◆タイトル:Global Tobacco Alternative Gums Market 2017-2021
◆商品コード:IRTNTR11429
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2017年3月8日
◆ページ数:70
◆資料形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:食品・飲料
◆販売価格オプション(消費税別)
Single User(1名利用)USD3,500 ⇒換算¥385,000見積依頼/購入/質問フォーム
Five User(~5名利用)USD4,500 ⇒換算¥495,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD5,000 ⇒換算¥550,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

当調査レポートでは、タバコ代替ガムの世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、タバコ代替ガムの世界市場規模及び予測、販売チャネル別分析、地域別分析/市場規模、主要国別分析、市場の成長要因、市場の課題、市場動向、競争状況などの情報をお届けいたします。

About Tobacco Alternative Gums
Tobacco alternative gums are products such as nicotine gums, which are used by smokers to quit smoking. Nicotine gum is a smoking cessation product, which helps smokers to gradually get off nicotine. Nicotine released from chewing nicotine gum is absorbed into the bloodstream through the lining of the mouth. Nicotine gums help the human body battle the strong urges for nicotine after cutting down on cigarettes. They are available in various dosages and can be consumed according to the level of addiction.

Technavio’s analysts forecast the global tobacco alternative gum market to grow at a CAGR of 7.52% during the period 2017-2021.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global tobacco alternative gum market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of tobacco alternative gum.

The market is divided into the following segments based on geography:
• Americas
• APAC
• Europe
• MEA

Technavio’s report, Global Tobacco Alternative Gums Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• GlaxoSmithKline
• Johnson & Johnson
• Novartis
• Reynolds American Incorporated

[Other prominent vendors]
• Alkalon
• Costco
• Revolymer
• Target
• Walgreen
• Wal-Mart

[Market driver]
• Increase in number of people quitting smoking
• For a full, detailed list, view our report

[Market challenge]
• Stringent government regulations
• For a full, detailed list, view our report

[Market trend]
• Introduction of new flavors
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

※You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【資料の目次】

Table of Contents
PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction
• Key market highlights

PART 05: Market landscape
• Market overview
• Global smoking cessation market
• Global tobacco alternative gums market
• Five forces analysis

PART 06: Market segmentation by nicotine content
• Global 2-mg nicotine gum market
• Global 4-mg nicotine gum market

PART 07: Market segmentation by distribution channel

PART 08: Geographical segmentation
• Tobacco alternative gums market in Americas
• Tobacco alternative gums market in Europe
• Tobacco alternative gums market in APAC
• Tobacco alternative gums market in MEA

PART 09: Key leading countries
• US
• Germany
• France
• China

PART 10: Market drivers

PART 11: Impact of drivers

PART 12: Market challenges

PART 13: Impact of drivers and challenges

PART 14: Market trends

PART 15: Vendor landscape
• Competitive scenario
• GlaxoSmithKline
• Johnson & Johnson
• Novartis
• Reynolds American Incorporated
• Other prominent vendors

PART 16: Appendix
• List of abbreviations

[List of Exhibits]

Exhibit 01: Percentage of people smoking in various countries 2015
Exhibit 02: Overview of global tobacco alternative gums market 2016
Exhibit 03: Global smoking cessation market 2016-2021 ($ billions)
Exhibit 04: Global tobacco alternative gums market 2016-2021 ($ billions)
Exhibit 05: Five forces analysis
Exhibit 06: Global tobacco alternative gums market by nicotine content 2016 and 2021
Exhibit 07: Global 2-mg nicotine gum market 2016-2021 ($ billions)
Exhibit 08: Global 4-mg nicotine gum market 2016-2021 ($ billions)
Exhibit 09: Global tobacco alternative gums market by distribution channel 2016
Exhibit 10: Global tobacco alternative gums market by geography 2016 and 2021
Exhibit 11: Tobacco alternative gums market in Americas 2016-2021 ($ billions)
Exhibit 12: Tobacco alternative gums market in Europe 2016-2021 ($ billions)
Exhibit 13: Tobacco alternative gums market in APAC 2016-2021 ($ billions)
Exhibit 14: Tobacco alternative gums market in MEA 2016-2021 ($ billions)
Exhibit 15: Key leading countries
Exhibit 16: Tobacco alternative gums market in US 2016-2021 ($ billions)
Exhibit 17: Tobacco alternative gums market in Germany 2016-2021 ($ billions)
Exhibit 18: Tobacco alternative gums market in France 2016-2021 ($ billions)
Exhibit 19: Tobacco alternative gums market in China 2016-2021 ($ billions)
Exhibit 20: Impact of drivers
Exhibit 21: Impact of drivers and challenges
Exhibit 22: Competitive assessment of major players in global tobacco alternative gums market
Exhibit 23: GlaxoSmithKline: Business segmentation by revenue 2015 ($ billions)
Exhibit 24: GlaxoSmithKline: Operating profit comparison 2014 and 2015 ($ billions)
Exhibit 25: GlaxoSmithKline: EBITDA comparison 2014 and 2015 ($ billions)
Exhibit 26: GlaxoSmithKline in global tobacco alternative gums market
Exhibit 27: Johnson & Johnson manufacturing facilities by geography
Exhibit 28: Johnson & Johnson: Business segmentation by revenue 2015 ($ billions)
Exhibit 29: Johnson & Johnson: Total sales comparison 2014 and 2015 ($ billions)
Exhibit 30: Johnson & Johnson: EBITDA comparison 2014 and 2015 ($ billions)
Exhibit 31: Johnson & Johnson in global tobacco alternative gums market
Exhibit 32: Novartis: Business segmentation by revenue 2015 ($ billions)
Exhibit 33: Novartis: Net sales comparison 2014 and 2015 ($ billions)
Exhibit 34: Novartis: Net income comparison 2014 and 2015 ($ billions)
Exhibit 35: Novartis in global tobacco alternative gums market
Exhibit 36: Reynolds American Incorporated: Nets sales comparison 2014 and 2015 ($ billions)
Exhibit 37: Reynolds American Incorporated: Operating income comparison 2014 and 2015 ($ billions)
Exhibit 38: Reynolds American Incorporated: Net income comparison 2014 and 2015 ($ billions)
Exhibit 39: Reynolds American Incorporated in global tobacco alternative gums market



【掲載企業】

GlaxoSmithKline, Johnson & Johnson, Novartis, Reynolds American Incorporated, Alkalon, Costco, Revolymer, Target, Walgreen, and Wal-Mart

【資料のキーワード】

タバコ代替ガム、タバコ代わりガム、ニコチンガム

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

★調査レポート[タバコ代替ガムの世界市場2017-2021]販売に関する免責事項
[タバコ代替ガムの世界市場2017-2021]についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆